🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The DAPA-HF trial demonstrated that dapagliflozin was able to reduce the ri...
Status
Completed
Location
Cheng Hsin General Hospital
Start Date
2020-05-29
Trial ID
NCT04575675
Heart failure (HF) is the most common nosology encountered in clinical prac...
Status
Recruiting
Location
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
Start Date
2023-10-01
Trial ID
NCT05769036
The purpose of the study is: * To evaluate the Heart Failure Risk Status (...
Status
Completed
Location
Multiple Locations
Start Date
2013-06
Trial ID
NCT03009175
Treatments Being Tested
Purpose: This study aimed to evaluate whether virtual reality technology p...
Status
Completed
Location
West german heart and vascular center, University hospital Essen,
Start Date
2024-01-01
Trial ID
NCT07250282
Treatments Being Tested
The purpose of the study is to compare, three months after implantable card...
Status
Completed
Location
CHU de Grenoble
Start Date
2014-01
Trial ID
NCT02045173
Treatments Being Tested
Central Sleep Apnoea (CSA) affects up to half of patients with severe heart...
Status
Suspended
Location
Royal Brompton and Harefield NHS Foundation Trust
Start Date
2014-06
Trial ID
NCT02203383
Treatments Being Tested
At present, the optimal treatment strategy for heart failure patients and m...
Status
Withdrawn
Location
Multiple Locations
Start Date
2016-12
Trial ID
NCT02985268
Treatments Being Tested
The purpose of this clinical trial is to evaluate the potential benefits of...
Status
Completed
Location
Multiple Locations
Start Date
2010-03
Trial ID
NCT01045343
Treatments Being Tested
Background: Recommendations for peri-operative management in patients with ...
Status
Recruiting
Location
Klinikum Fuerth
Start Date
2018-11-27
Trial ID
NCT04331249
Treatments Being Tested
Incretin therapy and sodium-glucose- transporter2 inhibitors (SGLT2i) are a...
Status
Completed
Location
Raffaele Marfella
Start Date
2017-09-01
Trial ID
NCT03282136
Treatments Being Tested